These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. Currier J AIDS Clin Care; 2007 May; 19(5):40-1. PubMed ID: 18398989 [No Abstract] [Full Text] [Related]
10. Update from the 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Brown T; Confrancesco J Hopkins HIV Rep; 2005 Jan; 17(1):4-5, 8. PubMed ID: 16419320 [No Abstract] [Full Text] [Related]
16. Lipoatrophy: a new "scarlet letter". Hoyt G Surviv News (Atlanta Ga); 2004; 15(2):8, 19. PubMed ID: 15124576 [No Abstract] [Full Text] [Related]
17. HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities. Moyle G; Carr A HIV Clin Trials; 2002; 3(1):89-98. PubMed ID: 11894812 [No Abstract] [Full Text] [Related]
18. Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates. Schmitz T; Weizsaecker K; Feiterna-Sperling C; Eilers E; Obladen M AIDS; 2006 Apr; 20(7):1082-3. PubMed ID: 16603869 [No Abstract] [Full Text] [Related]
19. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival. Leonard EG; McComsey GA Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657 [TBL] [Abstract][Full Text] [Related]
20. [Facial lipodystrophy in patients with HIV infections troublesome to treat]. Walther RA Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]